FME Fresenius Medical Care AG

40.27USD36.72 EUR · XETRA-4.77%Mkt Cap: 10.45B USDP/E: 12.32

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and di…

Institutional holders12 on file

Key Statistics

Company
Market Cap10.45B USD
Enterprise Value22.26B USD
Revenue (TTM)21.36B USD
Gross Profit5.52B USD
Net Income (TTM)1.07B USD
Revenue/Share78.23 USD
Last Price40.27 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees106.3K
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISINDE0005785802
Valuation
P/E (Trailing)12.32
P/E (Forward)9.64
PEG0.96
EV/EBITDA7.52
EV/Revenue1.04
P/S0.49
P/B0.74
EPS (TTM)3.27 USD
EPS (Forward)4.18 USD
52W Range
37.9519% of range50.34
52W High50.34 USD
52W Low37.95 USD
Profitability
Gross Margin25.62%
Oper. Margin10.10%
EBITDA Margin13.85%
Profit Margin4.98%
ROE7.35%
ROA3.16%
ROIC6.19%
ROCE7.38%
Growth
Revenue Growth1.10%
Earnings Growth-35.40%
Cash Flow & Leverage
Operating CF2.94B USD
CapEx (TTM)1.00B USD
FCF Margin7.66%
FCF Yield15.67%
Net Debt10.75B USD
Net Debt/EBITDA3.63
Net Debt/FCF6.57
Balance Sheet
Debt/Equity0.81
Current Ratio0.99
Quick Ratio0.57
Book Value/Sh54.07 USD
Cash/Share4.64 USD
Dividends
Fwd Div Rate1.63 USD
Trail. Div Rate1.63 USD
Div. Yield3.75%
5Y Avg Yield3.09%
Payout Ratio50.00%
Ex-Div DateMay 22, 2026
Pay Date—
Splits
Last Split3:1
Split DateJun 18, 2007
Analyst Consensus
Rating3.2 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)43.20 USD
Upside (mean)+7.3%
Target Range30.71 USD – 68.00 USD
30.71+7.3% to mean68.00
# Analysts17
Ownership
Shares Out.259.51M
Float205.21M
Insiders20.01%
Institutions53.31%
Technical
SMA 5043.44 (-7.3%)
SMA 20043.61 (-7.7%)
Beta0.79
S&P 52W Chg12.00%
Avg Vol (30d)1.08M
Avg Vol (10d)1.20M
Technical Indicators
RSI (14)34.3
MACD-0.2649
MACD Signal0.1491
MACD Hist.-0.4140
BB Upper46.95 USD
BB Middle44.22 USD
BB Lower41.48 USD
BB Width12.35%
ATR (14)1.345 USD
Vol Ratio (20d)1.49x

About Fresenius Medical Care (ETR: FME)

›

Fresenius Medical Care (ETR: FME) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 106,291 employees.

The shares were at 36.72 EUR on 19 November 2026, down 8.4% over 52 weeks. Its 52-week range is 34.60 EUR to 45.90 EUR: the price is 20.0% below the high and 6.1% above the low.

At a market capitalisation of 9.53B EUR, it trades at 12.3 times trailing earnings and 9.6 times forward earnings. The median trailing P/E of its 17 largest Medical Care Facilities peers is 24.4, a discount of 50% for FME. It pays a dividend yielding 3.75% (it pays out 50% of its earnings), against a median of 0.64% among the dividend payers in that peer group.

Fresenius Medical Care reports return on equity of 7.4%, an operating margin of 10.1% and revenue up 1.1% year over year.

Its debt exceeds its cash by 9.80B EUR, a debt-to-equity ratio of 0.81. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 17 analysts cover the stock, with an average rating of Hold; their mean price target of 39.39 EUR is 7.3% above the current price. The next earnings report is expected on 23 February 2027.